|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Jan 1, 2023
|
Q4 FY2021
As of Jan 2, 2022
|
Q4 FY2020
As of Jan 3, 2021
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets | |||||
| Cash and cash equivalents | |||||
| Short-term securities | |||||
| Restricted short-term marketable securities | |||||
| Accounts receivable, net | |||||
| Inventories, net | |||||
| Advances to suppliers, current | |||||
| Prepaid expenses and other current assets | |||||
| Assets classified as held for sale | |||||
| Total current assets | |||||
| Property, plant and equipment, net | |||||
| Operating lease right of use assets | |||||
| Intangible assets, net | |||||
| Advances to suppliers, non current | |||||
| Goodwill | |||||
| Deferred tax assets | |||||
| Other long-term assets | |||||
| Total assets | |||||
| Liabilities and Equity | |||||
| Current liabilities | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Contract liabilities, current portion | |||||
| Short-term debt | |||||
| Operating lease liabilities, current portion | |||||
| Liabilities classified as held for sale | |||||
| Total current liabilities | |||||
| Long-term debt | |||||
| Contract liabilities, net of current portion | |||||
| Operating lease liabilities, net of current portion | |||||
| Convertible debt | |||||
| Deferred tax liabilities | |||||
| Other long-term liabilities | |||||
| Total liabilities | |||||
| Equity (deficit) | |||||
| Ordinary shares, no par value (16,711,109 and 539,591 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively) | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Accumulated other comprehensive loss | |||||
| Net deficit attributable to the Company | |||||
| Noncontrolling interests | |||||
| Total equity (deficit) | |||||
| Total liabilities and equity (deficit) | |||||
| Common stock, shares issued (in shares) | |||||
| Common stock, shares outstanding (in shares) | |||||
Loading...
